LWMNY
PFE icon

Landmark Wealth Management (New York)’s Pfizer PFE Stock Holding History

Landmark Wealth Management (New York)’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$880K Buy
+31,328
New +$834K 0.24% 78
2022
Q2 		– Sell
-1,777
Closed -$1.78K – 140
2022
Q1 		$1.78K Buy
+1,777
New +$92.2K ﹤0.01% 85

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Landmark Wealth Management (New York)'s PFE Position: Q1 2026 in Review

Landmark Wealth Management (New York) opened a new position in Pfizer (PFE) in Q1 2026: 31,328 shares worth $880K. The stake represents 0.24% of the portfolio and ranks #78 among its holdings. This is a return to the name: Landmark Wealth Management (New York) previously reported a position in PFE as recently as Q1 2022.

Landmark Wealth Management (New York) first reported a position in PFE in Q1 2022 and has held it in 2 quarters since. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Landmark Wealth Management (New York) held 31,328 shares of Pfizer worth $880K as of Q1 2026.
  • Pfizer was a new Landmark Wealth Management (New York) position in Q1 2026.
  • Pfizer made up 0.24% of Landmark Wealth Management (New York)'s portfolio in Q1 2026, its #78 holding.
  • Landmark Wealth Management (New York) first reported a position in Pfizer in Q1 2022 and has held it in 2 quarters since.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Landmark Wealth Management (New York)'s 13F filing for Q1 2026, filed 29 Apr 2026.